Paper34873458
Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancer.
Yousafzai NA and 3 others. Am J Cancer Res, 2021. Cited by 55 papers, by iCite.
Cite this record
ConductScience Library. Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancer. Papers, record 34873458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34873458
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References136
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28689995 | SIRT1 Enhances the Survival of Human Embryonic Stem Cells by Promoting DNA Repair. | Stem Cell Reports | 2017 | https://conductscience.org/library/papers/28689995 | PubMed |
| 2 | 31043584 | SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31043584 | PubMed |
| 3 | 17694089 | Sirtuins: critical regulators at the crossroads between cancer and aging. | Oncogene | 2007 | https://conductscience.org/library/papers/17694089 | PubMed |
| 4 | 31258843 | An emerging role of CD9 in stemness and chemoresistance. | Oncotarget | 2019 | https://conductscience.org/library/papers/31258843 | PubMed |
| 5 | 18046409 | Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. | Nature | 2007 | https://conductscience.org/library/papers/18046409 | PubMed |
| 6 | 15902208 | An inhibitor of Bcl-2 family proteins induces regression of solid tumours. | Nature | 2005 | https://conductscience.org/library/papers/15902208 | PubMed |
| 7 | 31704472 | Emerging role of stem cell-derived extracellular microRNAs in age-associated human diseases and in different therapies of longevity. | Ageing Res Rev | 2020 | https://conductscience.org/library/papers/31704472 | PubMed |
| 8 | 17234790 | Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. | Cancer Res | 2007 | https://conductscience.org/library/papers/17234790 | PubMed |
| 9 | 28166203 | LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. | Oncogene | 2017 | https://conductscience.org/library/papers/28166203 | PubMed |
| 10 | 29890735 | Resveratrol Ameliorates Microcystin-LR-Induced Testis Germ Cell Apoptosis in Rats via SIRT1 Signaling Pathway Activation. | Toxins (Basel) | 2018 | https://conductscience.org/library/papers/29890735 | PubMed |
| 11 | 20007699 | BCR-ABL gene expression is required for its mutations in a novel KCL-22 cell culture model for acquired resistance of chronic myelogenous leukemia. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20007699 | PubMed |
| 12 | 16892051 | Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. | Nat Cell Biol | 2006 | https://conductscience.org/library/papers/16892051 | PubMed |
| 13 | 25884180 | Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells. | BMC Cancer | 2015 | https://conductscience.org/library/papers/25884180 | PubMed |
| 14 | 30273928 | KU70 Inhibition Impairs Both Non-Homologous End Joining and Homologous Recombination DNA Damage Repair Through SHP-1 Induced Dephosphorylation of SIRT1 in T-Cell Acute Lymphoblastic Leukemia (T-ALL) [corrected]. | Cell Physiol Biochem | 2018 | https://conductscience.org/library/papers/30273928 | PubMed |
| 15 | 30327428 | Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage. | J Biol Chem | 2018 | https://conductscience.org/library/papers/30327428 | PubMed |
| 16 | 21062352 | Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. | J Pineal Res | 2011 | https://conductscience.org/library/papers/21062352 | PubMed |
| 17 | 21078544 | Targeting apoptosis pathways in pancreatic cancer. | Cancer Lett | 2013 | https://conductscience.org/library/papers/21078544 | PubMed |
| 18 | 17151364 | Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. | N Engl J Med | 2006 | https://conductscience.org/library/papers/17151364 | PubMed |
| 19 | 21508974 | An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. | Nat Rev Cancer | 2011 | https://conductscience.org/library/papers/21508974 | PubMed |
| 20 | 14976264 | Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. | Science | 2004 | https://conductscience.org/library/papers/14976264 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42958661 | Xiaoyao San enhances the sensitivity of hepatocellular carcinoma to 5-fluorouracilautophagy modulation. | J Tradit Chin Med | 2026 | https://conductscience.org/library/papers/42958661 | PubMed |
| 42848173 | Arbutin as a promising cardioprotective anticancer adjuvant with doxorubicin in solid Ehrlich carcinoma through targeting NEK7-dependent inflammasome/SIRT1/caspase-3/oxidative stress pathways. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42848173 | PubMed |
| 42738658 | Antileukemic Activity of Sechium Hybrid H387 Extract Associated with SIRT1 Downregulation and p53 Acetylation in Human Chronic Myeloid Leukemia Cells. | Molecules | 2026 | https://conductscience.org/library/papers/42738658 | PubMed |
| 42511457 | Immunological Microenvironment Diversity in Homogeneous and Non-Homogeneous Oral Leukoplakia. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511457 | PubMed |
| 41304967 | Sirtuins as Therapeutic Targets for Treating Cancer, Metabolic Diseases, and Neurodegenerative Diseases. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41304967 | PubMed |
| 40944749 | Non-coding RNAs' pivotal importance in modulation of cancer sensitivity to Topotecan: a systematic review. | Med Oncol | 2025 | https://conductscience.org/library/papers/40944749 | PubMed |
| 40806596 | Sodium Caseinate Induces Apoptosis in Cytarabine-Resistant AML by Modulating SIRT1 and Chemoresistance Genes, Alone or in Combination with Cytarabine or Daunorubicin. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806596 | PubMed |
| 40591009 | SIRT1 as a masterful reciprocal regulator of molecular mechanisms and signaling pathways involved in tumor growth and expansion. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/40591009 | PubMed |
| 40538510 | Targeting the NAD+/SIRT1 axis: A metabolic strategy to overcome oxaliplatin resistance in colorectal cancer. | World J Gastroenterol | 2025 | https://conductscience.org/library/papers/40538510 | PubMed |
| 40517236 | Bypassing the guardian: regulated cell death pathways in p53-mutant cancers. | Cell Mol Biol Lett | 2025 | https://conductscience.org/library/papers/40517236 | PubMed |
| 40027307 | Global requirements for manufacturing and validation of clinical grade extracellular vesicles. | J Liq Biopsy | 2024 | https://conductscience.org/library/papers/40027307 | PubMed |
| 39766219 | Role of Nicotinamide in the Pathogenesis of Actinic Keratosis: Implications for NAD+/SIRT1 Pathway. | Biomolecules | 2024 | https://conductscience.org/library/papers/39766219 | PubMed |
| 39403142 | The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39403142 | PubMed |
| 39266959 | SIRT1-mediated deacetylation of FOXO3 enhances mitophagy and drives hormone resistance in endometrial cancer. | Mol Med | 2024 | https://conductscience.org/library/papers/39266959 | PubMed |
| 38865161 | Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma. | Cancer Biol Ther | 2024 | https://conductscience.org/library/papers/38865161 | PubMed |
| 38567911 | Water-soluble 4-(dimethylaminomethyl)heliomycin exerts greater antitumor effects than parental heliomycin by targeting the tNOX-SIRT1 axis and apoptosis in oral cancer cells. | Elife | 2024 | https://conductscience.org/library/papers/38567911 | PubMed |
| 38473244 | Advances in 3D Culture Models to Study Exosomes in Triple-Negative Breast Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473244 | PubMed |
| 38369747 | Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors. | Epigenetics | 2024 | https://conductscience.org/library/papers/38369747 | PubMed |
| 38322669 | The Implication of Growth Arrest-Specific 5 rs145204276 Polymorphism and Serum Expression of Sirtuin 1, Transforming Growth Factor-Beta, and microRNA-182 in Breast Cancer. | Clin Med Insights Oncol | 2024 | https://conductscience.org/library/papers/38322669 | PubMed |
| 38067304 | Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/38067304 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SIRT1 | 23411 | PubTator's text mining | https://conductscience.org/library/genes/23411 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34873458
GET https://conductscience.org/api/papers/v1/34873458/references?page=2